Global Hypercalcemia Treatment Market 2017-2021

Publisher Name :
Date: 19-Apr-2017
No. of pages: 70
Inquire Before Buying

Hypercalcemia is a condition in which the calcium level in the blood is above normal. Too much calcium in the blood can weaken the bones, create stones in the kidneys, and interfere with the functioning of the heart and the brain. Hypercalcemia refers to the condition where too much calcium enters the extracellular fluid or when there is insufficient calcium excretion from the kidneys. The cases of hypercalcemia are mainly caused by malignancy or hyperparathyroidism. Hypercalcemia is an outcome of overactive parathyroid glands. These four tiny glands are located near thyroid gland and each of them are about the size of a rice grain.

The analysts forecast global hypercalcemia treatment market to grow at a CAGR of 5.44% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global hypercalcemia treatment market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Hypercalcemia Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • AbbVie

  • Amgen

  • Merck

  • Novartis

  • OPKO Health


Other prominent vendors


  • DiaSorin

  • Rockwell Medical

  • Kyowa Hakko Kirin

  • Fujirebio


Market driver


  • Expanding label indications.

  • For a full, detailed list, view our report


Market challenge


  • Severe threat of damage to nervous system.

  • For a full, detailed list, view our report


Market trend


  • Growing focus on emerging economies.

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Global Hypercalcemia Treatment Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Key market highlights

PART 05: An overview of Hypercalcemia

PART 06: Pipeline Analysis

PART 07: Market landscape
Market overview
Five forces analysis

PART 08: Market segmentation by product type
Bisphosphonates
Glucocorticoids
Calcimimetic agents
Others

PART 09: Market segmentation by geography
Hypercalcemia treatment market in Americas
Hypercalcemia treatment market in EMEA
Hypercalcemia treatment market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
Market drivers
Impact of drivers on key customer segments
Market challenges
Impact of challenges on key customer segments

PART 12: Market trends
Combination therapy
Increase in outsourcing
Growing focus on emerging economies

PART 13: Vendor landscape
Competitive scenario

PART 14: Key vendor analysis
AbbVie
Amgen
Merck
Novartis
OPKO Health
Other prominent vendors

PART 15: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Body parts affected by high calcium
Exhibit 02: Pipeline landscape
Exhibit 03: Global hypercalcemia treatment market snapshot
Exhibit 04: Global hypercalcemia treatment market 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis in global hypercalcemia treatment market
Exhibit 06: Five forces analysis
Exhibit 07: Market segmentation by product type 2016
Exhibit 08: Bisphosphonates segment 2016-2021 ($ millions)
Exhibit 09: Glucocorticoids segment 2016-2021 ($ millions)
Exhibit 10: Calcimimetic agents segment 2016-2021 ($ millions)
Exhibit 11: Global hypercalcemia treatment market by geography 2016 and 2021
Exhibit 12: Global hypercalcemia treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 13: Market scenario in Americas
Exhibit 14: Hypercalcemia treatment market in Americas ($ millions)
Exhibit 15: Market scenario in EMEA
Exhibit 16: Hypercalcemia treatment market in EMEA ($ millions)
Exhibit 17: Market scenario in APAC
Exhibit 18: Hypercalcemia treatment market in APAC ($ millions)
Exhibit 19: Key approvals
Exhibit 20: Key factors driving the market growth
Exhibit 21: Impact of drivers
Exhibit 22: Impact of serum calcium concentration
Exhibit 23: Impact of challenges
Exhibit 24: Competitive structure analysis of global hypercalcemia treatment market 2016
Exhibit 25: Competitive analysis of global hypercalcemia market
Exhibit 26: AbbVie: Key highlights
Exhibit 27: AbbVie: Strength assessment
Exhibit 28: AbbVie: Strategy assessment
Exhibit 29: AbbVie: Opportunity assessment
Exhibit 30: Amgen: Key highlights
Exhibit 31: Amgen: Strength assessment
Exhibit 32: Amgen: Strategy assessment
Exhibit 33: Amgen: Opportunity assessment
Exhibit 34: Merck: Key highlights
Exhibit 35: Merck: Strength assessment
Exhibit 36: Merck: Strategy assessment
Exhibit 37: Merck: Opportunity assessment
Exhibit 38: Novartis: Strength assessment
Exhibit 39: Novartis: Strategy assessment
Exhibit 40: Novartis: Opportunity assessment
Exhibit 41: OPKO Health: Key highlights
Exhibit 42: OPKO Health: Strength assessment
Exhibit 43: OPKO Health: Strategy assessment
Exhibit 44: OPKO Health: Opportunity assessment

  • Global and China Human Microbiome Therapeutics Market Research by Company, Type & Application 2013-2025
    Published: 12-May-2018        Price: US 2000 Onwards        Pages: 86
    Summary Market Segment as follows: By Type - PDSs - PDCs By Application - Intestines And Stomach - Oral - Respiratory Tract - Others By Company - ENTEROME Bioscience - Rebiotix - Seres Therapeutics - Vedanta Biosciences - Bristol-Myers Squibb - Johnson & Johnson - Takeda Pharmaceutical The main contents of the report including:......
  • Global Anti-Inflammatory Therapeutics Market Size, Status and Forecast 2025
    Published: 11-May-2018        Price: US 3300 Onwards        Pages: 90
    This report studies the global Anti-Inflammatory Therapeutics market, analyzes and researches the Anti-Inflammatory Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - AbbVie Inc. - Pfizer Inc. - Merck & Co., Inc. - Johnson & Johnson - GlaxoSmithKline plc - AstraZeneca PLC - Amgen Inc - Novartis AG - F. Hoffmann-La R......
  • United States Acute Ischemic Stroke Therapeutics Market Report 2018
    Published: 10-May-2018        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Acute Ischemic Stroke Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), marke......
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Professional Survey Report 2018
    Published: 09-May-2018        Price: US 3500 Onwards        Pages: 103
    This report studies Brachytherapy Afterloaders, Brachytherapy Seeds in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Elekta - Theragenics - Eckert & Ziegler......
  • Global Microbiome Drugs Market Size, Status and Forecast 2025
    Published: 08-May-2018        Price: US 3300 Onwards        Pages: 95
    This report studies the global Microbiome Drugs market, analyzes and researches the Microbiome Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer - Second Genome - Seres Therapeutics - MaaT Pharma - Enterome Bioscience - MicroBiome Therapeutics - Ritter Pharmaceuticals - Rebiotix - OpenBiome Market se......
  • Systemic Mastocytosis - Pipeline Review, H1 2018
    Published: 08-May-2018        Price: US 2000 Onwards        Pages: 156
    Systemic Mastocytosis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Mastocytosis - Pipeline Review, H1 2018, provides an overview of the Systemic Mastocytosis (Gastrointestinal) pipeline landscape. Systemic mastocytosis is a disorder where mast cells are abnormally increased in multiple organs including the bone marrow. Symptoms include shortness of breath, low blood pressure,......
  • Global Acute Ischemic Stroke Therapeutics Market Research Report 2018
    Published: 07-May-2018        Price: US 2900 Onwards        Pages: 102
    In this report, the global Acute Ischemic Stroke Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Acute Ischemic Stroke Therapeutics in these regions, from 2013 to 2025 (forecast), covering - North America......
  • Global Acute Ischemic Stroke Therapeutics Sales Market Report 2018
    Published: 04-May-2018        Price: US 4000 Onwards        Pages: 108
    In this report, the global Acute Ischemic Stroke Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Acute Ischemic Stroke Therapeutics for these regions, from 2013 to 2025 (forecast), covering - United States - Chi......
  • Global and China Infantile Spasms Therapeutics Market Research by Company, Type & Application 2013-2025
    Published: 03-May-2018        Price: US 2000 Onwards        Pages: 89
    Summary Market Segment as follows: By Type - Oral - Injection By Application - Hospital - Clinic - Others By Company - H. Lundbeck - Mallinckrodt - Insys Therapeutics - Orphelia Pharma - Valerion Therapeutics - Catalyst Pharmaceuticals - Anavex Life Sciences - Retrophin The main contents of the report including: Section 1: P......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs